|
ZNF773 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.227200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.937100E-03 |
| Normal-vs-Stage2 |
7.311200E-01 |
| Normal-vs-Stage3 |
7.322300E-02 |
| Normal-vs-Stage4 |
6.724000E-03 |
| Stage1-vs-Stage2 |
1.568370E-01 |
| Stage1-vs-Stage3 |
1.208680E-04 |
| Stage1-vs-Stage4 |
9.70430000024614E-07 |
| Stage2-vs-Stage3 |
1.310210E-01 |
| Stage2-vs-Stage4 |
2.263500E-02 |
| Stage3-vs-Stage4 |
4.616600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.356400E-01 |
| Normal-vs-AfricanAmerican |
1.594760E-01 |
| Normal-vs-Asian |
9.504800E-01 |
| Caucasian-vs-AfricanAmerican |
1.273400E-01 |
| Caucasian-vs-Asian |
9.305200E-01 |
| AfricanAmerican-vs-Asian |
5.467800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.127800E-01 |
| Normal-vs-Female |
5.535900E-02 |
| Male-vs-Female |
1.177660E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.526370E-01 |
| Normal-vs-Age(41-60Yrs) |
1.469590E-01 |
| Normal-vs-Age(61-80Yrs) |
3.120800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.882000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.119600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.860400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.474500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.621580E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.420240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.128200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.801570E-03 |
| Normal-vs-Grade 2 |
7.600800E-03 |
| Normal-vs-Grade 3 |
1.175620E-01 |
| Normal-vs-Grade 4 |
4.138200E-03 |
| Grade 1-vs-Grade 2 |
1.464020E-02 |
| Grade 1-vs-Grade 3 |
1.639950E-04 |
| Grade 1-vs-Grade 4 |
3.25440000004118E-06 |
| Grade 2-vs-Grade 3 |
5.90069999999443E-05 |
| Grade 2-vs-Grade 4 |
2.49779999994537E-06 |
| Grade 3-vs-Grade 4 |
1.136570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.881800E-03 |
| Normal-vs-ccB subtype |
4.099600E-01 |
| ccA subtype-vs-ccB subtype |
2.696500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.234400E-01 |
| Normal-vs-N1 |
2.300600E-01 |
| N0-vs-N1 |
3.173800E-01 |
|
|
